ANAPTYSBIO INCANAPTYSBIO INCANAPTYSBIO INC

ANAPTYSBIO INC

No trades
See on Supercharts
Market capitalization
‪9.75 B‬MXN
−103.14MXN
‪−2.78 B‬MXN
‪291.41 M‬MXN
‪23.71 M‬
Beta (1Y)
0.49

About ANAPTYSBIO INC

CEO
Daniel R. Faga
Headquarters
San Diego
Employees (FY)
117
Founded
2005
ISIN
US0327241065
FIGI
BBG00PGGWL45
AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. It also offers SHM platform that replicate the natural process of somatic hypermutation embedded within the human immune system to rapidly develop a diverse range of therapeutic-grade antibodies in vitro. The company was founded by Andrew B. Cubitt, William J. Boyle, Kevin J. Kinsella, and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ANAB is 580.00 MXN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange ANAPTYSBIO INC stocks are traded under the ticker ANAB.
ANAPTYSBIO INC is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
ANAB stock is 0% volatile and has beta coefficient of 0.49. Check out the list of the most volatile stocks — is ANAPTYSBIO INC there?
One year price forecast for ANAPTYSBIO INC has a max estimate of 1337.86 MXN and a min estimate of 334.46 MXN.
ANAB earnings for the last quarter are −24.58 MXN whereas the estimation was −30.98 MXN which accounts for 20.65% surprise. Estimated earnings for the next quarter are −27.19 MXN. See more details about ANAPTYSBIO INC earnings.
ANAPTYSBIO INC revenue for the last quarter amounts to ‪57.84 M‬ MXN despite the estimated figure of ‪39.89 M‬ MXN. In the next quarter revenue is expected to reach ‪64.30 M‬ MXN.
Yes, you can track ANAPTYSBIO INC financials in yearly and quarterly reports right on TradingView.
ANAB net income for the last quarter is ‪−716.96 M‬ MXN, while the quarter before that showed ‪−650.31 M‬ MXN of net income which accounts for −10.25% change. Track more ANAPTYSBIO INC financial stats to get the full picture.
Today ANAPTYSBIO INC has the market capitalization of ‪9.75 B‬, it has decreased by 2.45% over the last week.
No, ANAB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ANAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANAPTYSBIO INC stock right from TradingView charts — choose your broker and connect to your account.
ANAB reached its all-time high on Jun 21, 2019 with the price of 1104.39 MXN, and its all-time low was 205.50 MXN and was reached on Nov 8, 2019.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 117.00 employees. See our rating of the largest employees — is ANAPTYSBIO INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ANAPTYSBIO INC technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ANAPTYSBIO INC stock shows the strong buy signal. See more of ANAPTYSBIO INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ANAPTYSBIO INC future price: according to them, ANAB price has a max estimate of 1337.86 MXN and a min estimate of 334.46 MXN. Read a more detailed ANAPTYSBIO INC forecast: see what analysts think of ANAPTYSBIO INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ANAPTYSBIO INC EBITDA is ‪−2.63 B‬ MXN, and current EBITDA margin is −901.65%. See more stats in ANAPTYSBIO INC financial statements.